临床试验

Clinical Feasibility of Cardiac Neuromodulation Therapy for Heart Failure With Preserved Ejection Fraction

NCT：NCT07598760 · NOT_YET_RECRUITING

NCT编号NCT07598760

状态NOT_YET_RECRUITING

开始日期2026-05-30

完成时间2028-11-30

SponsorBackBeat Medical Inc (INDUSTRY)

First posted2026-05-20

Last updated2026-05-20

简要摘要

This is an open-label pilot study to evaluate the feasibility of Cardiac Neuromodulation Therapy (CNT) in patients with high blood pressure and heart failure who require dual-chamber pacemaker implantation or replacement. The study will assess blood pressure and heart function at rest and during exercise, with and without CNT, for up to 12 months. Participants will receive the Moderato Plus device and complete scheduled follow-up visits. After study completion, CNT therapy will be discontinued and participants will return to standard medical care.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。